fashion -WSS

fashion

author：comprehensive 2025-08-06 04:47:21 - browse：3392

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Doctors increasingly discourage vaping amid mounting health concerns

WSS

How the drug

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Can U.S. cancer drug shortages be fixed?

Meadows told special counsel he could not recall Trump ever declassifying Mar

As obesity drug market grows, telehealth companies court payers

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Wildfire smoke exposes gaps in outdoor worker protections

Study: Spinal cord stimulation helps patients with paralysis walk again

Dobbs anniversary: the lost opportunity of abortion as health care

Abortion policy in the spotlight at Republican debate

Jerome Adams on the need for new antivirals for Covid

Kellogg’s is going to war over Mexico’s nutrition label rules

How to save PrEP access — and even expand it

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Affirmative action in medical school literally saved lives

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

hotspot

Doctors increasingly discourage vaping amid mounting health concerns

Kellogg’s is going to war over Mexico’s nutrition label rules

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Poland's lawmakers approve a divisive law on Russian influence

Abortion policy in the spotlight at Republican debate

CDC says it’s too soon to assess risk posed by Covid subvariant

leisure time

focus

hotspot

focus